Primary tabs

Cyclic Peptides for Eliminating Drug-Tolerant Tuberculosis

Anthony Baughn of the University of Minnesota in the U.S. will test a library of cyclic peptides to identify small molecules that impair the ability of the tuberculosis- causing bacterium M. tuberculosis to develop resistance to current drug therapies, for use in a new class of tuberculosis antibiotics.

Grant ID
OPP1067958
Show on Hub
On
Show on Spoke
On
Follow-on Funding
Off
Lead Funding Organization
Principal Investigator
Individual Funder Information
Funding Organization
Funding Amount (in original currency)
100000.00
Funding Currency
USD
Funding Amount (in USD)
100000.00
Project Type
Project Primary Sector
Project Subsector
Funding Date Range
-
Funding Total (In US dollars)
100000.00
Co-Funded
False